Leverage these CNS-focused solutions independently to address specific protocol requirements or combine for an end-to-end digital trial optimized for endpoint data accuracy in CNS studies:

eCOA & ELECTRONIC CLINICIAN RATINGS

BLINDED DATA
ANALYTICS

RATER TRAINING & CERTIFICATION

CENTRAL REVIEW

SCIENTIFIC
ADVISORY

With dozens of built-in electronic neurology and psychiatry clinical outcome assessments, our eCOA platform minimizes rater errors by applying internal logic, edit checks, audio/video recording capability, and on-screen guidance to facilitate ensure accurate, reliable COA data.

A must-have component to any CNS study, Signant’s unique analytics solution blends proprietary algorithms with clinical/statistical interpretation and analysis, helping study teams proactively mitigate data quality risks at all relevant levels of your study.

Leveraging our direct experience in CNS trials, our experts qualify, train, certify, and recalibrate raters throughout your studies to ensure consistency, accuracy, and standardization. Our technology enables gatekeeping of raters by qualification status to further safeguard study data.

Access a network of specialized, experienced raters who perform independent reviews of recorded assessments to validate scoring and administration consistency and accuracy, ensuring COA data reliability.

Our unrivaled and highly-experienced team of CNS science and medicine professionals, as well as clinical trial technology and operations experts, actively partner with study teams from launch to closeout to optimize clinical data quality and CNS study outcomes.

Improving CNS Study Outcomes
One Endpoint at a Time

Clinical research investigating novel treatments or therapies for Central Nervous System (CNS) diseases is as complicated and nuanced as are the conditions.

Signant SmartSignals clinical trial solutions and our unrivaled, direct experience in CNS science and clinical medicine help study teams support endpoints by addressing three primary challenges:

CONNECT WITH US